SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001607062-18-000340
Filing Date
2018-10-15
Accepted
2018-10-15 16:13:24
Documents
1
Period of Report
2017-01-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2141
  Complete submission text file 0001607062-18-000340.txt   3425
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 531 AIRPORT NORTH OFFICE PARK FORT WAYNE IN 46825
Business Address
Corrao Mark (Reporting) CIK: 0001634371 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25169 | Film No.: 181122355